Transplantation and Cellular Therapy

Best practice considerations by the American Society of Transplant and Cellular Therapy: Infection prevention and management after chimeric antigen receptor T cell therapy for hematological malignancies

Blood Advances

CAR T-cell toxicities: From bedside to bench, how novel toxicities inform laboratory investigations

The New England Journal of Medicine

Obecabtagene autoleucel in adults with B-cell acute lymphoblastic leukemia

Immunotherapy

The potential of phytomedicines to optimize CAR-T cell therapy in cancer

Frontiers in Immunology

CAR-T cell therapy clinical trials: Global progress, challenges, and future directions from ClinicalTrials.gov insights

The Lancet

In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma

Blood

Intrathecal chemotherapy as treatment for chimeric antigen receptor T cell (CAR T) therapy associated neurotoxicity

Transplantation and Cellular Therapy

Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome

Future Oncology

Establishing a successful outpatient CAR T-cell program with cilta-cel: Real-world experience from an expert roundtable

Blood

Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy